| NCT05918783 | Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer | RECRUITING | PHASE1 | 2025-05-28 | 2028-12-30 | 2027-05-30 |
| NCT07019194 | An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition | COMPLETED | PHASE1 | 2024-06-21 | 2024-07-15 | 2024-07-15 |
| NCT05919238 | Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma | RECRUITING | PHASE1 | 2024-05-15 | 2026-10-30 | 2026-05-30 |
| NCT05390944 | An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition | COMPLETED | PHASE1 | 2022-06-08 | 2022-08-01 | 2022-08-01 |
| NCT05391048 | An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition | COMPLETED | PHASE1 | 2022-06-06 | 2022-07-21 | 2022-07-21 |
| NCT05269316 | Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2022-02-11 | 2026-12-31 | 2026-12-31 |
| NCT04822961 | Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment | UNKNOWN | PHASE2 | 2021-12-31 | 2024-08 | 2024-05 |
| NCT05109832 | A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects | COMPLETED | PHASE1 | 2021-10-09 | 2021-12-06 | 2021-12-06 |
| NCT07030439 | A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State | COMPLETED | PHASE1 | 2021-07-18 | 2021-10-12 | 2021-10-12 |
| NCT04768868 | The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1 | 2021-02-25 | 2023-08-30 | 2023-04-30 |
| NCT04584515 | IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers | COMPLETED | PHASE1 | 2020-11-02 | 2021-05-27 | 2021-03-08 |
| NCT04351165 | BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects | COMPLETED | PHASE1 | 2020-10-29 | 2021-04-30 | 2021-02-11 |
| NCT04434482 | IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer | COMPLETED | PHASE1, PHASE2 | 2020-08-07 | 2024-04-29 | 2024-04-29 |
| NCT04169997 | A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2019-12-24 | 2026-06-30 | 2023-03-16 |
| NCT04089189 | Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer | COMPLETED | PHASE2 | 2019-10-28 | 2024-12-17 | 2023-06-30 |
| NCT04057729 | IMP4297 Food Effect Trial in Healthy Volunteers | COMPLETED | PHASE1 | 2019-07-22 | 2019-09-27 | 2019-09-27 |
| NCT03508011 | A Study of IMP4297 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2017-08-23 | 2020-12-16 | 2020-12-16 |
| NCT03507543 | The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2017-02-03 | 2021-03-17 | 2020-09-24 |